Ardent Health Partners (NYSE:ARDT) Issues FY 2025 Earnings Guidance

Ardent Health Partners (NYSE:ARDT) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.730-2.010 for the period, compared to the consensus EPS estimate of 1.930. The company issued revenue guidance of $6.2 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

Ardent Health Partners Stock Performance

Shares of ARDT stock traded down $0.49 during trading hours on Wednesday, reaching $13.96. 499,049 shares of the stock were exchanged, compared to its average volume of 369,997. Ardent Health Partners has a 12-month low of $13.63 and a 12-month high of $20.72. The business’s fifty day moving average is $15.29 and its two-hundred day moving average is $16.87. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. On average, sell-side analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Leerink Partners upped their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Morgan Stanley lowered their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price target for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Finally, Truist Financial cut their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $21.55.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.